Synthesis and biological evaluation of Ezetimibe analogs as possible cholesterol absorption inhibitors

Letters in Drug Design and Discovery

Volumn 8, Issue 6, 2011, Pages 500-505

  Wang, Yubin ^a   Haiqian, ^b   Huang, Wenlong ^b   Zhang, Huibin ^b   Zhou, Jinpei ^b  

^a NANJING TECH UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

2 Azetidinone derivatives; Cholesterol absorption inhibition; Enantiomerically pure

Indexed keywords

2 AZETIDINONE DERIVATIVE; AMIDE; ANTILIPEMIC AGENT; CARBON; CHOLESTEROL; EZETIMIBE; PYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DRUG ACTIVITY; DRUG SYNTHESIS; ENANTIOSELECTIVITY; EXPERIMENTAL ANIMAL; HAMSTER; ISCHEMIC HEART DISEASE; LIPID ABSORPTION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 79959348919     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018011795906776     Document Type: Article

References (16)

1. Iyer, S.P.; Yao, X.; Crona, J.H.; Hoos, L.M.; Tetzloff, G.; Davis, H.R.Jr.; Graziano, M.P.; Altmann, S.W.Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim. Biophys. Acta., 2005, 1722(3), 282-292. (Pubitemid 40354166)
2. Ros, E. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis, 2000, 151(2), 357-379. (Pubitemid 30618753)
3. Shepherd, J. The role of the exogenous pathway in hypercholesterolaemia. Eur. Heart. J., 2001, 3 (Suppl E), E2-E5. (Pubitemid 33713749)
4. Leitersdorf, E. Cholesterol absorption inhibition: filling an unmet need in lipid-lowering management. Eur. Heart. J., 2001, 3 (Suppl E), E17-E23. (Pubitemid 33713752)
5. Stone, N. Combination therapy: its rationale and the role of ezetimibe. Eur. Heart. J., 2002, 4 (Suppl J), J19-J22. (Pubitemid 35423722)
6. Heek, M.V.; Davis, H. Pharmacology of ezetimibe. Eur. Heart. J., 2002, 4 (Suppl J), J5-J8. (Pubitemid 35423720)
7. Sudhop, T.; Lütjohann, D.; Bergmann, K. Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol. Ther., 2005, 105(3), 333-341. (Pubitemid 40292725)
8. Vaccaro, W.D.; Sher, R.; Davis, H.R.Jr. 2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring. Bioorg. Med. Chem., 1998, 6(9), 1429-1437. (Pubitemid 28446221)
9. Burnett, D.A. β-Lactam Cholesterol Absorption Inhibitor. Curr. Med. Chem., 2004, 11(14), 1873-1887.
10. Rosenblum, S.B.; Huynh, T.; Afonso, A.; Davis, H.R.Jr. Synthesis of 3-Arylpropenyl, 3-Arylpropynyl and 3-Arylpropyl 2- Azetidinones as Cholesterol Absorption Inhibitors: Application of the Palladium-Catalyzed Arylation of Alkenes and Alkynes. Tetrahedron, 2000, 56(31), 5735-5742. (Pubitemid 30619323)
11. Wang, Y.B.; Zhang, H.B.; Huang, W.L.; Kong, J.; Zhou, J.P.; Zhang, B.B. 2-Azetidinone derivatives: Design, synthesis and evaluation of cholesterol absorption inhibitors. Eur. J. Med. Chem., 2009, 44(4), 1638-1643.
12. Frick, W.; Bauer-Schafer, A.; Bauer, J.; Girbig, F.; Corsiero, D.; Heuer, H.; Kramer, W. Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors. Bioorg. Med. Chem., 2003, 11(8), 1639-1642. (Pubitemid 36355846)
13. Buttero, P.D.; Molteni, G.; Roncoroni, M. Reductive ring opening of 2-azetidinones promoted by sodium borohydride. Tetrahedron Lett., 2006, 47(13), 2209-2211. (Pubitemid 43287884)
14. Baldwin, J.E.; Adlington, R.M.; Elend, A.S.; Smith, M.L. Enantiospecific synthesis of (3R, 4R)-3-amino-1-hydroxy-4-methyl pyrrolidin- 2-one(I-687,4140), an nmda receptor antagonist. Tetrahedron, 1995, 51(42), 11581-11594.
15. Kanth, J.V.Bhaskar.; Periasamy, M. Selective reduction of carboxylic acids into alcohols using sodium borohydride and iodine J. Org. Chem., 1991, 56, 5964-5965.
16. Salisbury, B.G.; Davis, H.R.; Burrier, R.E.; Burnett, D.A.; Bowkow, G.; Caplen, M.A.; Clemmons, A.L.; Compton, D.S.; Hoos, L.M.; McGregor, D.G. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis, 1995, 115(1), 45-63.